RTI Surgical® Announces Commercial Launch of the CervAlign® Anterior Cervical Plate System
September 24, 2019 07:05 ET
|
RTI Surgical Holdings, Inc.
DEERFIELD, Ill., Sept. 24, 2019 (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced the full commercial launch of the CervAlign®...
InveniAI Launches Suite of Products Powered by AlphaMeld™, an Artificial Intelligence Platform, to Enable Robust Decision Making for Multiple Stakeholders in the Life Sciences
September 17, 2019 08:30 ET
|
InveniAI
- CIMeld™, an AlphaMeld™ powered product for competitive/business intelligence, is set to launch at PharmaCI USA 2019 - Tailored suite of products to address high value questions accelerating...
Cancer Drugs Now Account for 27% of all New Drug Approvals in the U.S., According to Tufts Center for the Study of Drug Development
September 03, 2019 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Cancer drugs currently account for 27% of all new drug approvals in the United States since 2010, a dramatic increase from the 4% share of the 1980s, a...
MPHASE SIGNS PRODUCT LICENSE AND CONTENT AGREEMENT WITH ILEARNINGENGINES
August 20, 2019 17:51 ET
|
mPhase Technologies, Inc.
New York, NY, Aug. 20, 2019 (GLOBE NEWSWIRE) -- mPhase Technologies, Inc. (OTC:XDSL) (the “Company” or “mPhase”) is pleased to announce that it has signed a three-year Product License and Content...
Growth in Rare Disease R&D Is Challenging Development Strategy and Execution, According to Tufts Center for the Study of Drug Development
July 09, 2019 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, July 09, 2019 (GLOBE NEWSWIRE) -- Rare disease drug development, which now accounts for nearly one-third of all drugs in active R&D worldwide, presents scientific and operational...
InveniAI Appoints Industry Veteran Dr. Amit Agrawal to Board of Directors and Expands its Operations into the EU
July 02, 2019 08:31 ET
|
InveniAI
Dr. Agrawal, a biopharma Strategy and R&D leader, brings scientific and technology expertise to a world-class board of directors at InveniAI. InveniAI establishes presence in Basel, Switzerland...
Outotec ja kiinalainen Central South University sopivat tieteellisestä yhteistyöstä
June 24, 2019 06:00 ET
|
Outotec Oyj
OUTOTEC OYJ LEHDISTÖTIEDOTE 24.6.2019 KLO 13.00 Outotec ja kiinalainen Central South University sopivat tieteellisestä yhteistyöstä Outotec ja Central South University (CSU) ovat...
Outotec and Central South University from China to agree on scientific cooperation
June 24, 2019 06:00 ET
|
Outotec Oyj
OUTOTEC OYJ PRESS RELEASE JUNE 24, 2019 at 1:00 PM Outotec and Central South University from China to agree on scientific cooperation Outotec and Central South University (CSU) from China...
Vystar Contracts Rubber Expert Ranjit Matthan for Deproteinized Dry Rubber and Latex R&D
June 03, 2019 08:44 ET
|
Vystar Corp
WORCESTER, Mass., June 03, 2019 (GLOBE NEWSWIRE) -- Vystar Corp. (OTC Pink: VYST) extended and expanded its multi-year contract with Ranjit K. Matthan, Ph.D., an internationally renowned latex and...
Adoption of Artificial Intelligence Is High Across Pharmaceutical Industry, According to Tufts Center for the Study of Drug Development
May 07, 2019 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, May 07, 2019 (GLOBE NEWSWIRE) -- The pharmaceutical industry is adopting artificial intelligence (AI) on numerous fronts, from discovery and clinical development to risk assessment and...